Editorial Policies

Aims and Scope

Aims and scope
The JIAS welcomes submissions on HIV-related topics from across all scientific disciplines, including but not limited to:

  • Basic and biomedical sciences
  • Behavioural sciences and epidemiology
  • Clinical sciences
  • Health economics and health policy
  • Operations research and implementation sciences
  • Social sciences and humanities, including political sciences and media
The JIAS prioritizes submissions from operational research and implementation science as publication of such material can provide valuable information on various algorithms for monitoring and providing support for comprehensive, yet affordable and sustainable treatment, prevention and care programmes in different contexts.

Submission of HIV research carried out in low- and middle-income countries is strongly encouraged.

Article categories
The JIAS accepts submissions in the following categories
  • Original Research
  • Short report
  • Review
  • Debate
  • Commentary
  • Letter to the Editor
  • Viewpoint


Section Policies


Unchecked Open Submissions Checked Indexed Checked Peer Reviewed


Unchecked Open Submissions Checked Indexed Checked Peer Reviewed


Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Short report

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed


Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Letter to the Editors

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed


Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Peer Review Process

Editorial processes
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My account here. All submissions undergo an initial assessment by the Editors on whether the manuscript falls within the scope of the journal, is correctly formatted, follows ethics guidelines, and meets good standards of reporting. Manuscripts may be rejected at this stage at the discretion of the Editors. Submissions selected to undergo peer review will be sent to at least two independent reviewers; see Peer review policy for more information. The Editors aim to provide you with a first editorial response within eight weeks of submission. Editors make an editorial decision based on the reviewers' reports judging, in particular, methodological rigour, novelty and the extent of revisions needed. Manuscripts in which reviewers have raised major concerns, particularly on the study design or methodology, and those that require substantial revisions with unforeseeable outcomes, for example, re-analysis of data, may be rejected; a resubmission may be encouraged.

The Editors request revisions based on the reviewers' report; the Editors may include additional comments on matters to be addressed. The authors must address all comments by the reviewers and Editors in a point-by-point response, and a revised manuscript with changes highlighted must be submitted. The Editors set a deadline by which to return revisions, although authors can request extensions for editorial consideration and should state a reason for the request. The Editors assess revised manuscripts based on whether the authors have adequately addressed all comments. Re-reviews are only requested when revisions fall out of the technical expertise of the Editors. Further rounds of major revisions are usually not allowed, and manuscripts that have not been satisfactorily revised will be rejected. Minor revisions though may be requested as needed.

The Editors-in-Chief make the final decision on a manuscript. Once accepted, manuscripts proceed to the production stage, which consists of copy editing and typesetting. The article is created in the file formats, PDF, HTML, XML and ePub, and posted online as soon as the authors have approved the final version. Publications are indexed and archived automatically; see Indexing and Archiving for more information.

Peer review policy
The JIAS uses a single-blind peer review system, in which reviewers remain anonymous to the authors, although the authors' identity is known to the reviewers. All manuscripts are reviewed by at least two independent experts with experience in the subject area and selected by the Editors. Dedicated statistical reviewers may be used if needed. Reviewers have to declare any competing interests to the Editors. Authors can suggest peer reviewers during the submission step. Suggested peer reviewers should not have co-authored publications with any of the authors during the past five years, should not be current collaborators, and should not be members of the same institution. Suggested reviewers will be considered alongside potential reviewers identified by the Editorial team. Authors may also request exclusion of individuals as potential reviewers: those who have clear competing interests, are close collaborators, or have given input into the manuscript previously.

Peer reviewers are asked to consider the following guiding questions in their assessment of the manuscript:

  1. Does the manuscript address an important or timely issue?
  2. Is the methodology used sound and the conclusions drawn valid?
  3. Do the authors provide the context of the topic in a balanced way by referring to relevant and up-to.-date publications?
  4. Are the findings disaggregated by sex and analyzed by sex or gender?
In addition to providing comments for the authors, reviewers are given the following five options to indicate their recommendations to the Editors:

- Accept without revision
- Accept after discretionary revisions
- Accept after minor essential revisions
- Unable to decide on acceptance or rejection until the authors have responded to the major compulsory revisions
- Reject as not sufficiently sound
- Reject as not of sufficient priority to merit publishing in this journal.

Appeals and complaints
Please contact the Editorial office if you wish to appeal a rejection or make a complaint.


Publication Frequency

Accepted articles are published continuously online as soon as the final formatted files have been created and approved by the authors.


Open Access Policy

Open access publishing The JIAS is an open access publication and its content is therefore free for anybody to access online, to read and download, as well as to copy and disseminate for educational purposes. Articles are published immediately upon acceptance and production of the final formatted version. When published online, articles are assigned a DOI number (digital object identifier) whereby it becomes possible to search and cite them without delay.



ArchivingArticles published in the JIAS are archived in the following repositories:



Indexing Articles published in the JIAS are deposited in the following indexing services:

Impact factor: 6.296 (2016 Journal Citations Reports® Science Edition - a Clarivate Analytics product).


Publication fee

Publication fees
Please note that the JIAS charges a publication fee on all accepted articles. This is necessary to ensure continued open access publication. The publication fee applies to all articles irrespective of the article category, with exception of Letters to the Editor and commissioned Commentaries. An article up to eight final typeset PDF pages will incur a publication fee of USD 2400. Additional pages will incur a fee of USD 70 per page. The total costs will be charged to the authors upon acceptance of the manuscript. Charges are quoted exclusive of value added tax (VAT). The total costs will be charged to the authors upon acceptance of the manuscript. Authors will also receive further information during the production phase of their accepted articles.

Many institutions provide central funding for open-access publications. For a list of such institutions, please click here. For a list of funding bodies that allow their grants to be used for open-access publications, please click here. Members of the International AIDS Society receive a 15% discount on the publication fee. Authors should include their valid membership number in the cover letter upon submission.

Waiver Policy - please see here.

WITHDRAWAL OF MANUSCRIPT If you withdraw your manuscript after it has been peer reviewed, or after it has been typeset (but not yet published) you will be charged according to the following:

For peer review: USD 500 per article
For peer review and typesetting: USD 650 per article


Advertising, sponsorship and donations

Please contact the Editorial office if you are interested in advertising on our journal’s website. We also gladly receive inquiries on sponsorship and donations to support publications from authors in low- and middle-income countries.



The JIAS publishes supplements, special issues and thematic series on own initiative or based on proposals by authors, which can be sent to the Editorial office. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full-length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of conference abstract collections. For further information, please contact the Editorial office.


Comments on publications

Readers are welcome to comment on articles published in the JIAS. A comment option can be accessed from a specific article page; users must be registered and logged in to use this function. The Editors will screen submitted comments and inappropriate material will be removed.


Citation convention

When citing publications from the JIAS, references should be formatted according to journal guidelines. As the JIAS is an online-only journal, articles are given a unique number. Page numbers within publications are not for citation purposes. The format of the JIAS citations are Authors: Title. J Int AIDS Soc Year, Volume number:Article number. DOI.


Standards of reporting

Standards of reporting
The JIAS endorses international standards of reporting. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals guidelines produced by ICMJE as a reference standard of reporting. Authors are also referred to the EQUATOR network website for further information on the available reporting guidelines for health research, and the MIBBI Portal for prescriptive checklists for reporting biological and biomedical research where applicable. A number of checklists are available for various study designs, including randomized controlled trials (CONSORT), systematic reviews (PRISMA), observational studies (STROBE), meta-analyses of observational studies (MOOSE) and diagnostic accuracy studies (STARD). For systematic reviews, an additional file should be provided by the authors listing all details concerning the search strategy. Please refer to the Cochrane Reviewers' Handbook for an example of how a search strategy should be presented.

Guidelines on mutation nomenclature are provided by the Human Genome Variation Society, and authors should use the recommended gene name by referring to the appropriate genetic nomenclature database, for example, HUGO for human genes, and the International Committee on Standardized Genetic Nomenclature for Mice. When describing human phenotypes, please use standardized terms, such as those proposed by the Elements of Morphology working group (see http://research.nhgri.nih.gov/morphology/index.cgi).

Contributions from pharmaceutical companies or other commercial organizations should follow the Good Publication Practice guidelines for pharmaceutical companies, which also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.

The JIAS supports international standards of reporting of trials, in particular, prospective registering and numbering of clinical trials. Clinical trials are defined by the World Health Organization as all phase I to IV trials, which are research studies that prospectively assign human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Trials need to be registered prior to submission in a suitable, publicly available registry. Links to existing registries can be found through ICMJE here or through the primary registers that participate in the WHO International Clinical Trials Registry Platform. The trial registration number should be included as the last line of the manuscript Abstract.

Reporting by gender and race
Submitting authors shall include data disaggregated by sex (and, whenever possible, by race) and provide an analysis of gender and racial differences. The authors should include the number and percentage of men, women and, if appropriate, transgender persons, who participated in the research study. Anatomical and physiological differences between men and women (height, weight, body fat-to-muscle ratios, cell counts, hormonal cycles, etc.), as well as social and cultural variables (socio-economic, education, access to care, etc.), should be taken into consideration in the presentation of data and/or analysis of the results. If statistically significant differences were found between men and women or between different racial or cultural groups in the effects of the studied intervention, the implications, if any, for clinical and/or public health should be adequately discussed. If the research study was specific to one sex/gender, the reasons for this should be clearly stated.

Ethical policies
The JIAS is a member of the Committee on Publication Ethics (COPE) and endorses the World Association of Medical Editors' (WAME's) Policy Statement on Geopolitical Intrusion on Editorial Decisions. All submitted manuscripts are scanned for plagiarism and may be rejected if significant overlap with other published material is detected. Work presented in submitted manuscripts may not have been previously published; nor may the same manuscript be submitted for consideration to another journal simultaneously. Any misconduct by authors in reporting their data, for example, falsification, will lead to rejection of their manuscript and other consequences decided on by the Editors. Please see COPE and International Committee of Medical Journal Editors (ICMJE) for further information on ethical issues in publishing.

It is understood that all authors listed on submitted manuscripts have read and agreed to its content, and meet the authorship requirements as detailed by ICMJE here. In brief, contributors can be listed as authors if they: 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; AND 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; AND 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help or writing assistance, or a head of department, who provided only general support.

Ethical approval
Experimental research described in the manuscript must have been performed with the approval of an appropriate ethics review board. Research carried out on humans must be in compliance with the Helsinki Declaration, and any experimental research on animals must have followed internationally recognized guidelines. A statement on the ethical aspects, including the consent procedure followed, must be included in the Methods section of the manuscript. The Editors may reject manuscripts where the research has not been carried out within an ethical framework. For all articles that include information or photographs relating to individuals, written and signed consent from each patient to publish must also be made available if requested by the Editors. Confidentiality of study participants must be ensured at all stages of research and reporting.

Competing interests
Authors are required to submit a statement on competing interests, which exist when personal or financial relationships with persons or organizations may influence the interpretation of the data or how the author's work is presented. For details, see ICMJE's policy on competing interests here. In brief, all financial competing interests must be disclosed in this statement (reimbursements, fees, funding, salary payments from or ownership of any stocks or shares in an organization that may in any way gain or lose financially from the publication of the manuscript, either now or in the future, or applications for patents relating to the content of the manuscript), as well as non-financial competing interests (such as political, personal, religious, ideological, academic and/or intellectual interests) that are related to the work submitted. The competing interest statement should be included in the manuscript and will be published in the final article. If no competing interests exist, please state in this section, "The author declare (or The author declares) that they have no competing interests."

Copyright and libel
Legal responsibility to ensure that no material is published that infringes copyright or that includes libellous or defamatory content lies with the Journal of the International AIDS Society's publisher, the International AIDS Society. If a manuscript is judged by the journal Editors to include potentially libellous content, authors will be requested to adjust wording as necessary.

Commercial writers and editors
The involvement of scientific (medical) writers or anyone else who assisted with the preparation of the manuscript content should be acknowledged, along with their source of funding, as described in the European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.

Journal of the International AIDS Society | eISSN 1758-2652 | Editors-in-Chief: Susan Kippax and Kenneth Mayer

*2016 Journal Citation Reports® Science Edition - a Clarivate Analytics product.

Disclaimer: The Journal of the International AIDS Society is an official journal of and is published by the International AIDS Society. The costs of the Journal of the International AIDS Society are secured by the International AIDS Society. This support does not in any way affect the editorial independency of the Journal of the International AIDS Society. Material published in the journal is entirely independent of the opinion of external sponsors and the society.